The SNMMI said it had been in communication with Humana since November 2020 regarding its denial of coverage of PET/CT and SPECT/CT procedures.
According to the statement, Humana would not provide coverage because the procedures were “experimental/investigational” and “not identified as widely used and generally accepted for the proposed uses as reported in nationally recognized peer-reviewed medical literature.”
The payer also reversed its decision to deny coverage of the imaging procedures when used to identify gastric and esophageal oncologic indications earlier this year.
Becker’s 3rd Annual Fall Chief Pharmacy Officer Summit is the top tier event that the people leading the future of pharmacy convene. This 3-day event is built specifically for Chief Pharmacy Officers and senior pharmacy leaders. The sessions examine the workforce, financial and clinical priorities shaping pharmacy today. Becker’s is where candid discussions flourish and new ideas thrive. Becker's 3rd Annual Fall Chief Pharmacy Officer Summit
